{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:12:29Z","timestamp":1780917149765,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014786","name":"Northern Border University","doi-asserted-by":"publisher","award":["NBU-CRP-2025-2043"],"award-info":[{"award-number":["NBU-CRP-2025-2043"]}],"id":[{"id":"10.13039\/501100014786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130475","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:36:26Z","timestamp":1763346986000},"page":"130475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Precision engineering of adalimumab fab variants enhances TNF-\u03b1 neutralization and structural stability"],"prefix":"10.1016","volume":"131","author":[{"given":"Abida","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Huma H.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Al-Bazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer A.","family":"Banjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmcl.2025.130475_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.bmcl.2025.130475_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells","volume":"2","author":"Farrugia","year":"2016","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.bmcl.2025.130475_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115080","article-title":"Tackling TNF-\u03b1 in autoinflammatory disorders and autoimmune diseases: from conventional to cutting edge in biologics and RNA- based nanomedicines","volume":"201","author":"Andretto","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bmcl.2025.130475_bb0020","first-page":"101","article-title":"Visvanathan S. Anti-TNF Antibodies: Lessons from the Past, Roadmap for the Future. In: Chernajovsky Y, Nissim A, eds. Therapeutic Antibodies","author":"Shealy","year":"2008","journal-title":"Springer"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130475_bb0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","article-title":"Anti-TNF-\u03b1 therapies: the next generation","volume":"2","author":"Palladino","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell. Oncol."},{"issue":"7","key":"10.1016\/j.bmcl.2025.130475_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-\u03b1: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130475_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17460441.2021.1846516","article-title":"Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis","volume":"16","author":"Pelechas","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"Hetland","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bmcl.2025.130475_bb0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies","volume":"2","author":"Harding","year":"2010","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2024.184394","article-title":"TNF receptors: structure-function relationships and therapeutic targeting strategies","volume":"1867","author":"Lo","year":"2025","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"38","key":"10.1016\/j.bmcl.2025.130475_bb0070","doi-asserted-by":"crossref","first-page":"27059","DOI":"10.1074\/jbc.M113.491530","article-title":"Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor \u03b1-associated diseases from a molecular view *","volume":"288","author":"Hu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bmcl.2025.130475_bb0075","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/ijms19030768","article-title":"Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis","volume":"19","author":"Lim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bmcl.2025.130475_bb0080","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.3390\/jcm13216537","article-title":"Next-generation immunotherapy: advancing clinical applications in Cancer treatment","volume":"13","author":"Garg","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.bmcl.2025.130475_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104588","article-title":"Innovations in cancer immunotherapy: a comprehensive overview of recent breakthroughs and future directions","volume":"206","author":"Hsu","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.bmcl.2025.130475_bb0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/10781552251324896","article-title":"Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer","volume":"31","author":"Ali","year":"2025","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"12","key":"10.1016\/j.bmcl.2025.130475_bb0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jtct.2024.11.008","article-title":"Immune checkpoint inhibition and CAR T-cells: no longer exhausted?","volume":"30","author":"Minehart","year":"2024","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.bmcl.2025.130475_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100220","article-title":"Leveraging network pharmacology for drug discovery: integrative approaches and emerging insights","volume":"27","author":"Li","year":"2025","journal-title":"Medicine in Drug Discovery"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130475_bb0105","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1007\/s00210-024-03625-3","article-title":"Harnessing network pharmacology in drug discovery: an integrated approach","volume":"398","author":"Joshi","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bmcl.2025.130475_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108455","article-title":"Black seed (Nigella sativa) extract enhances early and late apoptosis through activation of caspase-3 mediated regulatory pathway in LC540 cells: a network pharmacological and molecular docking approach","volume":"118","author":"Gopi","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bmcl.2025.130475_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108134","article-title":"Targeting cyclin-dependent kinase 2 CDK2: insights from molecular docking and dynamics simulation \u2013 a systematic computational approach to discover novel cancer therapeutics","volume":"112","author":"Chagaleti","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bmcl.2025.130475_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108073","article-title":"Identification of novel CA IX inhibitor: pharmacophore modeling, docking, DFT, and dynamic simulation","volume":"110","author":"Packiapalavesam","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bmcl.2025.130475_bb0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00284-024-03875-7","article-title":"Immunomodulation in non-traditional therapies for methicillin-resistant Staphylococcus aureus (MRSA) management","volume":"81","author":"Subbarayudu","year":"2024","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.bmcl.2025.130475_bb0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.csbj.2022.12.022","article-title":"Network-based approaches for modeling disease regulation and progression","volume":"21","author":"Galindez","year":"2023","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130475_bb0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/biom11020334","article-title":"Anti-TNF alpha antibody Humira with pH-dependent binding characteristics: a constant-pH molecular dynamics, Gaussian accelerated molecular dynamics, and in vitro study","volume":"11","author":"Hong","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmcl.2025.130475_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrep.2025.102005","article-title":"Development and validation of a recombinant human TNF-\u03b1 based ELISA to detect and quantify adalimumab","volume":"42","author":"Saini","year":"2025","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0145","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/s41467-023-37668-6","article-title":"Automated optimisation of solubility and conformational stability of antibodies and proteins","volume":"14","author":"Rosace","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bmcl.2025.130475_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107774","article-title":"Computational engineering the binding affinity of adalimumab monoclonal antibody for designing potential biosimilar candidate","volume":"102","author":"Khan","year":"2021","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmcl.2025.130475_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","article-title":"TNF activity and T cells","volume":"101","author":"Mehta","year":"2018","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130475_bb0160","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bmcl.2025.130475_bb0165","author":"Bank RPD"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bmcl.2025.130475_bb0175","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bmcl.2025.130475_bb0180","doi-asserted-by":"crossref","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: the therapeutic structural antibody database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bmcl.2025.130475_bb0185","doi-asserted-by":"crossref","first-page":"D1368","DOI":"10.1093\/nar\/gkab1050","article-title":"SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker","volume":"50","author":"Schneider","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bmcl.2025.130475_bb0190","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: the structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bmcl.2025.130475_bb0195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcc.21303","article-title":"Crystal contacts as nature\u2019s docking solutions","volume":"31","author":"Krissinel","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bmcl.2025.130475_bb0205","first-page":"163","article-title":"Detection of Protein Assemblies in Crystals. In: R. Berthold M, Glen RC, Diederichs K, Kohlbacher O, Fischer I, eds. Computational Life Sciences","author":"Krissinel","year":"2005","journal-title":"Springer"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130475_bb0210","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"20","key":"10.1016\/j.bmcl.2025.130475_bb0215","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/bioinformatics\/btz184","article-title":"FoldX 5.0: working with RNA, small molecules and a new graphical interface","volume":"35","author":"Delgado","year":"2019","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130475_bb0220","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0225","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2020203","article-title":"BioPhi: a platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning","volume":"14","author":"Prihoda","year":"2022","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bioinformatics\/btaa1102","article-title":"SoluProt: prediction of soluble protein expression in Escherichia coli","volume":"37","author":"Hon","year":"2021","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.bmcl.2025.130475_bb0235","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.bmcl.2025.130475_bb0240","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.bmcl.2025.130475_bb0245","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bmcl.2025.130475_bb0250","series-title":"GROMACS 2022.4 Manual. Published online November 16","author":"Bauer","year":"2022"},{"issue":"25","key":"10.1016\/j.bmcl.2025.130475_bb0255","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bmcl.2025.130475_bb0260","article-title":"An open source C library for solvent accessible surface area calculations","author":"FreeSASA","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.bmcl.2025.130475_bb0265","article-title":"The interpretation of protein structures: estimation of static accessibility","volume":"55(3):379-IN4","author":"Lee","year":"1971","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bmcl.2025.130475_bb0270","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N \u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"17","key":"10.1016\/j.bmcl.2025.130475_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/1.4872239","article-title":"Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity","volume":"140","author":"Harrach","year":"2014","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bmcl.2025.130475_bb0280","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0285","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.bmcl.2025.130475_bb0290","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.90.075503","article-title":"Predicting crystal structures: the Parrinello-Rahman method revisited","volume":"90","author":"Marto\u0148\u00e1k","year":"2003","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.bmcl.2025.130475_bb0295","article-title":"Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay","volume":"11(477):eaat3356","author":"Berkhout","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bmcl.2025.130475_bb0300","doi-asserted-by":"crossref","DOI":"10.36648\/0975-9344.11.2.135","article-title":"Production and characterization of a new variant of an anti-Tnf\u03b1 antibody with improved affinity and potency","volume":"11","author":"Tabasinezhad","year":"2019","journal-title":"Int J Drug Dev & Res"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130475_bb0305","doi-asserted-by":"crossref","first-page":"e16373","DOI":"10.1371\/journal.pone.0016373","article-title":"Humanization and Characterization of an Anti-Human TNF-\u03b1 Murine Monoclonal Antibody. Chin WC, ed","volume":"6","author":"Chiu","year":"2011","journal-title":"PLoS One"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:34:06Z","timestamp":1780914846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S0960894X25003841"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130475","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision engineering of adalimumab fab variants enhances TNF-\u03b1 neutralization and structural stability","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130475"}}